Covariate-Adaptive Optimization in Online Clinical Trials

References

• Antognini AB, Zagoraiou M (2011) The covariate-adaptive biased coin design for balancing clinical trials in the presence of prognostic factors. Biometrika 98(3):519–535.Crossref, Google Scholar
• Atkinson AC (1982) Optimum biased coin designs for sequential clinical trials with prognostic factors. Biometrika 69(1):61–67.Crossref, Google Scholar
• Ben-Tal A, Nemirovski A, Roos C (2002) Robust solutions of uncertain quadratic and conic-quadratic problems. SIAM J. Optim. 13(2):535–560.Crossref, Google Scholar
• Berndt ER, Cockburn IM (2013) Price indexes for clinical trial research: A feasibility study. Technical report, National Bureau of Economic Research, Cambridge, MA.Crossref, Google Scholar
• Bertsimas D, Brown DB, Caramanis C (2011) Theory and applications of robust optimization. SIAM Rev. 53(3):464–501.Crossref, Google Scholar
• Bertsimas D, Johnson M, Kallus N (2015) The power of optimization over randomization in designing experiments involving small samples. Oper. Res. 63(4):868–876.Link, Google Scholar
• Bhat N, Farias VF, Moallemi CC, Sinha D (2019) Near optimal A-B testing. Management Sci. Forthcoming.Google Scholar
• Efron B (1971) Forcing a sequential experiment to be balanced. Biometrika 58(3):403–417.Crossref, Google Scholar
• Efron B, Tibshirani RJ (1994) An Introduction to the Bootstrap (CRC Press, Boca Raton, FL).Crossref, Google Scholar
• Fisher RA (1935) The Design of Experiments (Oliver & Boyd, Edinburgh, Scotland, UK).Google Scholar
• Greevy R, Lu B, Silber JH, Rosenbaum P (2004) Optimal multivariate matching before randomization. Biostatistics 5(2):263–275.Crossref, Google Scholar
• Kapelner A, Krieger A (2014) Matching on-the-fly: Sequential allocation with higher power and efficiency. Biometrics 70(2):378–388.Crossref, Google Scholar
• Lin W (2013) Agnostic notes on regression adjustments to experimental data: Reexamining Freedman’s critique. Ann. Appl. Statist. 7(1):295–318.Crossref, Google Scholar
• Morgan KL, Rubin DB (2012) Rerandomization to improve covariate balance in experiments. Ann. Statist. 40(2):1263–1282.Crossref, Google Scholar
• Morris C (1979) A finite selection model for experimental design of the health insurance study. J. Econom. 11(1):43–61.Crossref, Google Scholar
• Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31(1):103–115.Crossref, Google Scholar
• Rosenbaum PR, Rubin DB (1983) The central role of the propensity score in observational studies for causal effects. Biometrika 70(1):41–55.Crossref, Google Scholar
• Rosenbaum PR, Rubin DB (1985) Constructing a control group using multivariate matched sampling methods that incorporate the propensity score. Amer. Statist. 39(1):33–38.Crossref, Google Scholar
• Rosenberger WF, Sverdlov O (2008) Handling covariates in the design of clinical trials. Statist. Sci. 23(3):404–419.Crossref, Google Scholar
• Taves DR (1974) Minimization: A new method of assigning patients to treatment and control groups. Clinical Pharmacology Therapeutics 15(5):443–453.Crossref, Google Scholar
• Therneau T, Grambsch P (2000) Modeling Survival Data: Extending the Cox Model (Springer-Verlag, New York).Crossref, Google Scholar
• U.S. Food and Drug Administration (2015) The drug development process—Step 3: Clinical research. Accessed December 22, 2018, http://www.fda.gov/ForPatients/Approvals/Drugs/ucm405622.htm.Google Scholar